SCHEMBL24844798

SCHEMBL24844798

O=C(O)C1CC(O)(c2ccc(Cn3ccnc3)cc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 10/20 0.53
CYP19A1 P11511 5/20 0.52
CYP11B1 P15538 4/20 0.50
CYP11B2 P19099 4/20 0.50
CYP1A2 P05177 3/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
MEN1 O00255 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 1/20 0.50
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49
QPCT Q16769 1/20 0.49
CYP4Z1 Q86W10 1/20 0.49
QPCTL Q9NXS2 1/20 0.49
CYP17A1 P05093 1/20 0.48
CYP2A6 P11509 1/20 0.48
CYP2B6 P20813 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24844794 0.86 CYP19A1 (0.50) TBXAS1CYP19A1CYP11B1CYP11B2POLB
SCHEMBL24844793 0.77 TBXAS1 (0.56) TBXAS1CYP19A1CYP11B1CYP11B2CYP1A2
Hydrochloric Acid SCHEMBL10529727 0.72 TBXAS1 (0.53) TBXAS1CYP19A1CYP17A1
SCHEMBL1024261 0.72 CYP11B1 (0.84) TBXAS1CYP19A1CYP11B1CYP11B2CYP1A2
SCHEMBL29239316 0.72 TBXAS1 (0.72) TBXAS1CYP19A1CYP11B1CYP11B2CYP1A2
SCHEMBL4492287 0.72 CYP19A1 (0.75) TBXAS1CYP19A1CYP11B1CYP11B2CYP1A2
SCHEMBL24844882 0.72 TBXAS1 (0.56) TBXAS1CYP19A1CYP11B1CYP11B2CYP1A2
SCHEMBL24844753 0.72 TBXAS1 (0.56) TBXAS1CYP19A1CYP11B1CYP11B2CYP1A2
SCHEMBL24845649 0.72 TBXAS1 (0.56) TBXAS1CYP19A1CYP11B1CYP11B2CYP1A2
Oxalic Acid SCHEMBL11534580 0.71 CYP19A1 (0.81) TBXAS1CYP19A1CYP11B1CYP11B2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240336638-A1 IMIDAZOLE COMPOUND, AND INTERMEDIATE AND APPLICATION THEREOF ZHUGE, Guoqin (CN) 2024-10-10 US disclosed
CN-115557898-B Imidazole compound, intermediate and application thereof 诸葛国琴 2024-08-20 CN disclosed
WO-2023274257-A1 IMIDAZOLE COMPOUND, AND INTERMEDIATE AND APPLICATION THEREOF 诸葛国琴 2023-01-05 WO disclosed
CN-115557898-A Imidazole compound, intermediate and application thereof 诸葛国琴 2023-01-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240336638-A1 IMIDAZOLE COMPOUND, AND INTERMEDIATE AND APPLICATION THEREOF PINK1, TFPI, PLAT TBXAS1 226/4885CYP19A1 1775/4885CYP11B1 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.